Among the many struggles faced by the digital therapeutics industry is the difficulty of designing and running effective clinical trials of digital therapeutics.
It goes without saying that artificial intelligence (AI), machine learning (ML), generative AI (GenAI), and large language models (LLMs) are already transforming industry, refining and acce
Everyone’s talking about AI these days and it can be easy to get lost in the whirlwind of terms, like machine learning, generative AI, large language models, and natural language processing
In a new episode of the pharmaphorum podcast, host Nicole Raleigh speaks with Dr Brigham Hyde, co-founder and CEO of Atropos Health, and Ardy Arianpour, co-founder and CEO of SEQSTER, about
AstraZeneca easily delivered on chief executive Pascal Soriot’s pledge to deliver $45 billion in revenues by 2023, set a decade earlier as he fended off a takeover bid by
It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.